Besides, NNT-AS1 was aberrantly expressed in sarcoma, stomach adenocarcinoma, liver hepatocellular carcinoma, colon adenocarcinoma, and rectum adenocarcinoma, but the differences were not significant. This evidence concerns the gene NNT and rectum adenocarcinoma.